PARVEEN JAIN

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Breast Cancer in Transgenders: Narrative Review
  Indian Journal of Medical and Paediatric Oncology 2024 DOI: 10.1055/s-0041-1740140
  +Save
• KRAS mutation as a mechanism of resistance to Alectinib in ALK rearranged NSCLC
  Current Problems in Cancer: Case Reports 2021 DOI: 10.1016/j.cpccr.2021.100055
  +Save
• Identification of a novel ALK variant intrinsically resistant to crizotinib
  Current Problems in Cancer: Case Reports 2020 DOI: 10.1016/j.cpccr.2020.100040
  +Save
• EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature
  Clinical Lung Cancer 2020 DOI: 10.1016/j.cllc.2020.05.016
  +Save
• Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India
  Current Problems in Cancer 2020 DOI: 10.1016/j.currproblcancer.2020.100571
  +Save
• Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
  Japanese Journal of Clinical Oncology 2019 DOI: 10.1093/jjco/hyz012
  +Save